Login

REGENEREX PHARMA, INC.

regenerexpharmainc.com

What Do They Do?

Develops and markets wound dressings and creams, alongside treatment protocols, for home-health providers, state Medicaid programs and international healthcare programs.

How Do They Make Money?

No revenue reported yet.

Who Are Their Customers?

The company is developing managed-care agreements with southeastern state Medicaid programs and pursuing regional distributors in Asian and Middle Eastern markets; it expects to serve government-funded home-care providers and other healthcare programs.

How Are They Changing?

Since the FY2024 annual report
Latest quarter: Q2 FY2025, the three months to Sep 30, 2025
Net income
▲ +54% (Loss)
vs −$529.6K in Q2 FY2024
  • Sep 4, 2026 The independent auditor stopped providing services to the company The company is seeking a successor auditor and working to complete periodic reports.
  • May 6, 2026 The company terminated its chief financial officer The board appointed Don E. Ray as interim CFO.
  • Sep 3, 2025 Company agreed to develop and distribute collagen wound-care products The agreement gives Regenerex exclusive worldwide wound-care marketing rights and requires minimum purchases.
  • Jul 31, 2025 Company added ovine collagen to wound-care formulations The new formulations combine ovine nano-collagen with the company’s QBx technology.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support